Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of White Blood Cell Count with Treatment Response to Cefepime vs Piperacillin-Tazobactam.

American journal of respiratory and critical care medicine·2026
Same author

The Role of the Respiratory Microbiome in Pneumonia.

Clinics in chest medicine·2026
Same author

Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

In sepsis, circulating bacterial DNA correlates with disease severity and is filtered by the lungs.

American journal of respiratory and critical care medicine·2026
Same author

Reply to Hamilton et al. and chen et al.

American journal of respiratory and critical care medicine·2026
Same author

Temporal Trends in Pregnancy Rate, Live Birth Rates, and Rates of Gestational Outcomes, 2012-2023.

O&G open·2026
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
查看所有相关文章

相关实验视频

Updated: May 29, 2025

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

8.6K

微生物组和肺部免疫功能

Jennifer M Baker1, Robert P Dickson2

  • 1Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Clinics in chest medicine
|January 31, 2025
PubMed
概括
此摘要是机器生成的。

肺微生物组或呼吸道微生物群在肺免疫和疾病中起着关键作用. 未来的研究将专注于开发针对肺微生物组的疗法,以调节免疫反应.

关键词:
免疫功能受损的宿主肺部微生物组是如何形成的微生物生态学 微生物生态学肺部免疫力 肺部免疫力

更多相关视频

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.5K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.7K

相关实验视频

Last Updated: May 29, 2025

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

8.6K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.5K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.7K

科学领域:

  • 肺免疫学 肺免疫学
  • 微生物组研究的研究.
  • 翻译医学是一种翻译医学.

背景情况:

  • 肺部微生物组领域在过去十年中取得了显著的进步.
  • 新出现的证据将呼吸道微生物群与肺免疫和病原发生联系起来.
  • 这一领域对于翻译和临床研究至关重要.

研究的目的:

  • 审查最近关于肺微生物对肺免疫功能的影响的见解.
  • 确定未来调查的关键领域.
  • 为开发新型免疫调节疗法提供信息.

主要方法:

  • 关于肺部微生物组和免疫功能的最新研究的文献综述.
  • 综合有关呼吸道微生物群与宿主免疫系统相互作用的当前知识.
  • 确定研究缺口和未来方向.

主要成果:

  • 人们越来越认识到肺微生物组在调节肺免疫反应方面的重要作用.
  • 特定的微生物组成与不同的免疫特征和疾病状态有关.
  • 了解这些相互作用对于促进肺部健康至关重要.

结论:

  • 肺微生物组是维持肺免疫恒温的关键因素.
  • 进一步的研究对于利用呼吸道微生物组的治疗潜力至关重要.
  • 准肺部微生物组为开发肺部疾病新疗法提供了有希望的途径.